• Biotin-XX Tyramide Reagent for Surface Proteomics

  2026-08-31

  Biotin-XX Tyramide Reagent, also known as biotin-LC-LC-tyramide, is an HRP-dependent probe for localized tyramide signal amplification and membrane-impermeant cell surface labeling. Its polar linker supports selective extracellular deposition, while product-specific solvent and storage data define practical handling boundaries.

• Rapamycin and Lysosomal Assay Design

  2026-08-31

  Rapamycin (Sirolimus) is more than a general mTOR probe: it can help test how nutrient signaling intersects with lysosomal damage and unconventional α-synuclein secretion. This guide translates mechanistic findings from human dopamine neurons into rigorous assay design, controls, and interpretation.

• Dual-Action p38α Inhibitors and Dephosphorylation

  2026-08-30

  The reference study shows that selected kinase inhibitors can do more than block p38α catalytic activity: they can also expose the activation-loop phospho-threonine to WIP1, accelerating dephosphorylation. This structure-guided mechanism suggests a route toward kinase inhibitors whose potency and selectivity arise from coordinated control of kinase activity and phosphatase access.

• Radicicol: Hsp90 Inhibitor Mechanism and Models

  2026-08-29

  Radicicol is a potent Hsp90 inhibitor with additional biochemical activity against PDK3, Topo VI, and other ATP-dependent enzymes. Its reported applications include adipocyte differentiation, ovarian carcinoma apoptosis, and inflammation studies in a sepsis model.

• 2-Hydroxypropyl-β-cyclodextrin Protocol Guide

  2026-08-29

  2-Hydroxypropyl-β-cyclodextrin is a water-soluble cyclic oligosaccharide used to screen inclusion complex formation and improve the aqueous handling of poorly soluble hydrophobic compounds. In the absence of directly matched paper evidence, use it as a drug formulation excipient or pharmaceutical solubility improvement aid, not as proof of improved bioavailability or as a therapeutic agent.

• 3-Methyladenine: Autophagy Research Guide

  2026-08-28

  3-Methyladenine (3-MA) is a widely used autophagy research tool that inhibits class III phosphoinositide 3-kinase activity through Vps34-associated signaling. Its time-dependent effects on class I and class III PI3K require matched controls, flux measurements, and cautious interpretation in cancer research.

• AZD6482 for Reliable Cell Assays

  2026-08-28

  AZD6482 (SKU A5478) provides a data-backed starting point for selective PI3Kβ perturbation in cell viability, proliferation, and cytotoxicity workflows. This scenario-based guide covers concentration selection, solvent control, assay interpretation, cross-domain limitations, and practical supplier evaluation.

• Influenza Hemagglutinin (HA) Peptide Workflow

  2026-08-27

  Use the HA tag peptide to elute tagged proteins under gentle, antibody-competitive conditions while preserving protein interactions that harsh methods can disrupt. This workflow connects reproducible HA-tag purification with mechanistic assays inspired by the NEDD4L–PRMT5 colorectal cancer study.

• Alternariol and the Fibrosis Translation Gap

  2026-08-27

  Alternariol (AOH) is more than an emerging foodborne mycotoxin: it is a mechanistically rich research tool for connecting environmental exposure with hepatic stellate cell activation, apoptosis, cytochrome P450 biology, and fibrosis-related phenotypes. This thought-leadership article examines recent LX-2 omics evidence, outlines practical study parameters, compares AOH with related Alternaria toxins, and identifies the limitations that translational researchers must address before moving toward risk assessment or detoxification strategies.

• Nifedipine (BAY-a-1040) Assay Workflows

  2026-08-26

  Nifedipine (BAY-a-1040) provides a practical way to perturb L-type calcium signaling while preserving clear separation between established calcium assays and exploratory liver, iron, and fungal applications. This workflow emphasizes solvent control, orthogonal readouts, and careful interpretation of PXR-related findings rather than treating nifedipine as a PXR agonist.

• PD0325901: Linking MEK Signals to Cell Fate

  2026-08-26

  PD0325901 is a selective MEK inhibitor that connects RAS/RAF/MEK/ERK pathway perturbation with proliferation, apoptosis, and cell-fate analysis. This article develops an assay framework inspired by new WDR36–glycolysis findings in human blastoid models while clearly separating established evidence from exploratory applications.

• TAK-715: Selective p38 MAPK Inhibitor

  2026-08-25

  TAK-715 is a selective p38 MAPK inhibitor that targets p38α with a reported IC50 of 7.1 nM. Product data support its use in cytokine signaling modulation, inflammation studies, and rheumatoid arthritis research, while mechanistic evidence on dual-action p38α inhibition should not be attributed to TAK-715 without direct testing.

• SIRT3–SUMO Control of Treg Differentiation in Asthma

  2026-08-25

  Hu and Liu identify a metabolic mechanism linking SIRT3 SUMOylation, fatty acid oxidation, N-glycosylation, and regulatory T-cell differentiation in asthma. The study combines bioinformatic network analysis, an OVA-sensitized asthma model, primary CD4+ T-cell differentiation, and molecular perturbation to connect immune-cell phenotype with metabolic control, while also suggesting practical assays for separating proliferation from differentiation.

• Thapsigargin: From Calcium Stress to Translation Strategy

  2026-08-24

  Thapsigargin is more than a calcium-depletion reagent: it is a controllable SERCA pump inhibitor for connecting intracellular calcium homeostasis with ER stress, apoptosis, and translational control. This thought-leadership guide shows how researchers can use it to build mechanistically resolved, translationally relevant experiments without confusing an acute pharmacological perturbation with a disease mechanism.

• Tiamulin Metabolism Across Farm Animal Species

  2026-08-23

  The reference study used UHPLC–quadrupole/time-of-flight mass spectrometry to map Tiamulin biotransformation across rats, chickens, swine, goats, and cows, identifying 26 metabolites and substantial interspecies variation. Its findings refine candidate marker residues for regulatory monitoring, particularly in swine and chickens, and show why metabolism data should not be transferred between species without validation.

450 records 6/30 page Previous Next First page 上5页 678910 下5页 Last page